Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
11.16 SEK | +5.28% | -15.33% | +231.16% |
Chart calendar Ascelia Pharma AB
Upcoming events on Ascelia Pharma AB
Past events on Ascelia Pharma AB
2024-02-09 04:00 am | Q4 2023 Earnings Call |
2024-02-08 | Q4 2023 Earnings Release |
2023-11-23 10:10 am | Redeye Life Science Day |
2023-11-13 10:30 am | Extraordinary Shareholders Meeting |
2023-11-08 04:00 am | Q3 2023 Earnings Call |
2023-11-07 | Q3 2023 Earnings Release |
2023-08-31 12:00 am | HC Andersen Capital Life Science Seminar |
2023-08-18 04:00 am | Q2 2023 Earnings Call |
2023-08-18 01:30 am | Q2 2023 Earnings Release |
2023-08-08 02:00 am | SPARKLE Phase 3 Study Results Call |
2023-06-23 03:00 am | European Association for the Study of the Liver Congress |
2023-06-13 03:00 am | European Society of Gastrointestinal and Abdominal Radiology Meeting |
2023-05-31 08:30 am | ABGSC Life Science Summit |
2023-05-25 07:00 am | Investor Day |
2023-05-11 04:00 am | Q1 2023 Earnings Call |
2023-05-10 | Q1 2023 Earnings Release |
2023-05-04 08:00 am | Annual General Meeting |
2023-03-14 09:00 am | Investor Meeting |
2023-02-10 04:00 am | Q4 2022 Earnings Call |
2023-02-10 02:00 am | Q4 2022 Earnings Release |
Annual results
Fiscal Period | December | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 |
---|---|---|---|---|---|---|---|
Net sales Million SEK | Released Forecast Spread | 0,00 0,00 - | 0,00 0,00 - | 0,00 0,00 - | 0,00 0,00 - | 0,00 0,00 - | 0,00 |
EBITDA Million SEK | Released Forecast Spread | 0,00 0,00 - | -93,4 -98,0 4.67% | -138 -134 -3.02% | -147 -129 -14.4% | -111 -116 4.38% | -46,5 |
EBIT Million SEK | Released Forecast Spread | -37,4 -44,0 15.02% | -93,4 -98,0 4.67% | -138 -134 -2.64% | -147 -129 -14.18% | -111 -116 4.38% | -46,5 |
Earnings before Tax (EBT) Million SEK | Released Forecast Spread | 0,00 0,00 - | -99,7 -96,1 -3.8% | -130 -129 -0.25% | -133 -129 -3.62% | 0,00 0,00 - | -37,0 |
Net income Million SEK | Released Forecast Spread | 0,00 0,00 - | -98,7 -96,0 -2.81% | -126 -127 0.47% | -131 -129 -2.12% | 0,00 0,00 - | -37,0 |
EPS SEK | Released Forecast Spread | 0,00 0,00 - | -3,76 -3,66 -2.73% | -3,82 -3,85 0.78% | -3,77 -3,73 -1.21% | 0,00 0,00 - | -1,29 |
Announcement Date | 22/08/19 | 16/02/21 | 10/02/22 | 10/02/23 | 09/02/24 | - |
Quarterly results
Fiscal Period | December | 2021 Q4 | 2022 Q1 | 2022 Q2 | 2022 Q3 | 2022 Q4 | 2023 Q2 | 2023 Q3 | 2023 Q4 | 2024 Q1 | 2024 Q2 | 2024 Q3 | 2024 Q4 |
---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Net sales Million SEK | Released Forecast Spread | 0,00 0,00 - | 0,00 0,00 - | 0,00 0,00 - | 0,00 0,00 - | 0,00 0,00 - | 0,00 0,00 - | 0,00 0,00 - | 0,00 | 0,00 | 0,00 | 0,00 | |
EBITDA Million SEK | Released Forecast Spread | -52,2 -39,0 -33.76% | -33,0 | -14,0 | -14,0 | -14,0 | -16,0 | ||||||
EBIT Million SEK | Released Forecast Spread | -39,2 -36,0 -8.78% | -32,6 -37,0 11.97% | -32,7 -37,0 11.75% | -29,6 -36,0 17.73% | -52,2 -39,0 -33.76% | -21,4 -33,0 35.27% | -14,0 | -14,0 | -14,0 | -16,0 | ||
Earnings before Tax (EBT) Million SEK | Released Forecast Spread | -36,1 -36,0 -0.37% | -30,0 -37,0 18.84% | -23,8 -37,0 35.68% | -26,1 -36,0 27.53% | -53,2 -39,0 -36.51% | |||||||
Net income Million SEK | Released Forecast Spread | -35,1 -36,0 2.58% | -29,1 -37,0 21.42% | -22,8 -37,0 38.36% | -26,0 -36,0 27.89% | -53,4 -40,0 -33.46% | -40,3 | ||||||
EPS SEK | Released Forecast Spread | -1,53 -3,53 56.66% | -1,19 | -0,63 -0,90 30% | |||||||||
Announcement Date | 10/02/22 | 11/05/22 | 18/08/22 | 04/11/22 | 10/02/23 | 18/08/23 | 08/11/23 | 09/02/24 | - | - | - | - |
Past sector events for Ascelia Pharma AB
Today | GEMPHARMATECH CO., LTD.: Q1 2024 Earnings Release |
Today | GEMPHARMATECH CO., LTD.: Q4 2023 Earnings Release |
2024-04-26 01:00 am | BB BIOTECH AG: Q1 2024 Earnings Release |
2024-04-25 | BIDE PHARMATECH CO., LTD.: Q4 2023 Earnings Release |
2024-04-25 | PHARMARESOURCES (SHANGHAI) CO., LTD.: Q1 2024 Earnings Release |
2024-04-25 | HINOVA PHARMACEUTICALS INC.: Q1 2024 Earnings Release (Projected) |
2024-04-25 | BEIJING SUN-NOVO PHARMACEUTICAL RESEARCH CO., LTD.: Q4 2023 Earnings Release |
2024-04-25 | CHEMPARTNER PHARMATECH CO., LTD.: Q4 2023 Earnings Release |
2024-04-25 07:00 am | MORPHIC HOLDING, INC.: Q1 2024 Earnings Release |
2024-04-25 02:00 am | PURETECH HEALTH PLC: Q4 2023 Earnings Release |
Net sales - Quarter - Rate of surprise
Quarterly earnings - Rate of surprise
Net sales - Annual - Rate of surprise
Annual profits - Rate of surprise
- Stock Market
- Equities
- ACE Stock
- Calendar Ascelia Pharma AB